Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
BPC-157 is available for research purposes to qualified licensed professionals only and is not intended for retail or consumer use
By targeting the intestine, PAS-LAR can cause or exacerbate diabetes mellitus by strongly inhibiting GLP-1 or GIP secretion
There is never any down time with these injections
Clinical trials showed that 9 out of 10 patients experienced improvement within 4 weeks, with 69% achieving at least a clinically significant reduction in symptoms
many patients successfully transition to GLP-1 therapy post-lactation
SKIN BARRIER: Fast absorption into the skin to provide relief for dry, itchy skin and strengthens the skin barrier for healthy glowing skin
US$ 22.88
US$ 29.90
US$ 21.49
US$ 28.55
US$ 26.80
US$ 24.45
US$ 20.01
